Antibiotics Associated With Clostridium difficile Infection.

Rafey, Abdur; Jahan, Shah; Farooq, Umer; Akhtar, Furqana; Irshad, Memoona; Nizamuddin, Summiya; Parveen, Azra

Rafey, Abdur; Jahan, Shah; Farooq, Umer; Akhtar, Furqana; Irshad, Memoona; Nizamuddin, Summiya; Parveen, Azra.

Afiliación

Rafey A; Department of Internal Medicine and Infectious Diseases, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, PAK.
Jahan S; Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, PAK.
Farooq U; Department of Internal Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, PAK.
Akhtar F; Department of Infectious Diseases, Bahria International Hospital, Lahore, PAK.
Irshad M; Department of Infectious Diseases, Aga Khan University Hospital, Karachi, PAK.
Nizamuddin S; Department of Microbiology, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, PAK.
Parveen A; Department of Internal Medicine and Infectious Diseases, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, PAK.

Cureus ; 15(5): e39029, 2023 May.

Article en En | MEDLINE | ID: mdl-37323360

Palabras clave

ceftriaxone; ciprofloxacin; clostridium difficile; levofloxacin; meropenem; piperacillin/tazobactam; vancomycin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article